Crossmark

Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer

Crossref DOI link: https://doi.org/10.1186/s12890-018-0760-z

Published Online: 2019-01-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patout, Maxime http://orcid.org/0000-0002-1366-8726
Guisier, Florian

Brune, Xavier

Bohn, Pierre

Romieu, Anthony

Sarafan-Vasseur, Nasrin

Sesboüé, Richard

Renard, Pierre-Yves

Thiberville, Luc

Salaün, Mathieu
Funding

Funding for this research was provided by:

ADIR (2011)
License Information

Text and Data Mining valid from 2019-01-07
More Information

Article History

Received: 14 December 2017

Accepted: 6 December 2018

First Online: 7 January 2019

Ethics approval

: All animal experiments were approved by Rouen University animal research committee (approval n° 0312–01).

: Not applicable.

: • LT received a grant research from Mauna Kea Technologies (€ 1000); was invited as speaker at the International Conference on Cellvzio® Users in 2010 and 2011 (no fee) by Mauna Kea Technologies; LT is listed as co-author on a patent related to pCLE, shared between Rouen University and Mauna Kea Technologies (patent WO2008020130 A3).• MS was consultant for a medical board for Mauna Kea Technologies in 2014 (€ 750).• Other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.